Catherine M. Engelbert

Catherine M. Engelbert, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Royalty Pharma plc and Mcdonalds Corp. We count 8 filings; the first trade dates from 25 June 2021 and the latest from 5 June 2026.

No open-market sale appears; the market trades are 2 purchases worth €228k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 6 share grants.

On 8 June 2026 came the latest disclosure, a share grant in Royalty Pharma plc. The last purchase on record was published on 4 August 2023, which is 1,171 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.